Stephen J. Hoffman, Director at ALLOS THERAPEUTICS INC (ALTH), sold 136,286 shares at $6.76 ($962K) on 2010-01-07, disclosed to the SEC on 2010-01-11.
Scheduled sale ($962k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.76 | 45,429 | $307K | 31.9% |
| 2 | $7.11 | 45,429 | $323K | 33.6% |
| 3 | $7.30 | 45,428 | $332K | 34.5% |
| Total | $7.06 avg | 136,286 | $962K | 100% |
| Filing → |
| GNCA | BUY | 2014-02-11 | $3.0M | — | Filing → |
| DRNA | BUY | 2014-02-05 | $3.0M | — | Filing → |
| ACRX | BUY | 2012-05-31 | $968K | — | Filing → |